Athira Pharma, Inc.
ATHA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $16 | $12 | $11 | $23 |
| - Cash | $21 | $20 | $26 | $48 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | -$4 | -$7 | -$14 | -$25 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$7 | -$9 | -$15 |
| % Margin | – | – | – | – |
| Net Income | -$7 | -$7 | -$9 | -$15 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.68 | -1.78 | -2.3 | -3.9 |
| % Growth | 5.6% | 22.6% | 41% | – |
| Operating Cash Flow | -$5 | -$7 | -$15 | -$26 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$5 | -$7 | -$15 | -$26 |